Health Economics and Outcomes Research

Identify the evidence that reveals your value

Work with industry-recognized experts who apply scientific methodologies to conduct the full scope of health economics and outcomes research for effective strategic planning. We combine rigorous, technical expertise with an understanding of local markets and multiple disease states to deliver relevant, transparent, and credible results to help inform practical strategies and tactics that communicate a robust portfolio of value-based evidence.

Meet the experts

Comparative Effectiveness Research

Generate the evidence that payers demand

When the gold standard of head-to-head clinical trial data is limited or unavailable, manufacturers turn to Xcenda for evidence synthesis through systematic review and meta-analysis. Applying more than two decades of experience in conducting literature reviews, developing dossiers, and performing complex statistical analyses in numerous therapeutic areas, we provide turnkey support that includes initial literature evaluations, meta-analysis, and publication in scientific, peer-reviewed journals. Leverage our expertise in economic modeling and database studies in addition to value propositions to demonstrate the real-world application of results for your products.

Let's look at your data

Strategic Staffing Solutions

Flexible staffing to meet your most critical priorities

Our customized contract arrangements support:

Unexpected new projects
Short-term internal staffing gaps
Full-time or long-term hiring freezes
Field-based product value presentations to payers

See our team in action

Economic Models

Design credible, transparent, user-friendly models that payers trust

Identify patient trends. Simplify complex disease states and methodologies, including Markov models. And communicate value via our deep knowledge of Section 114 through a wide array of visually impactful, easy-to-use tools. Using enhanced graphics, navigation, and macros, showcase multiple data endpoints including cost-effectiveness, budget impact, or burden of disease. Our flexible training solutions also ensure your account executives are well-versed in tool comprehension for optimized customer installation and guidance.

340+

Economic models developed

50+

Therapeutic areas of expertise

Learn more

Global Market Access Strategy

Access global solutions for local launch success

Turn to Xcenda for a deeper understanding of the approval and decision-making processes related to coverage, reimbursement, and pricing in both established and emerging markets. Understand how HTA agencies make coverage decisions. From market research and HEOR strategy to medical communications and evidence generation, Xcenda helps global market access teams prepare a product value portfolio that local decision makers find most relevant.

Connect with market experts Subscribe to HTA Quarterly

Global Market Access Strategy Case Study

Carving a unique place among generics in a global marketplace

Learn how Xcenda helped a phase 2 specialty product successfully secure formulary positioning in a highly generic class in preparation for a multi-country launch.

Read the case study

Outcomes Analyzers

Prove effectiveness and value in real-world populations

Outcomes Analyzers are tools designed to capture and analyze an array of inputs — from pharmacy, medical, and EMR claims to patient satisfaction and laboratory results. Through this platform, real-world data stories can be revealed, whether through outcomes-based contracting, adherence program evaluation, treatment patterns and guidelines compliance, healthcare resource utilization and cost evaluations, risk assessment/identification in patient populations, quality metric evaluation and improvement, pre-post interventions, and predictive modeling based on retrospective claims.

Request a demo See our areas of expertise

Quality Improvement Programs

Increase collaboration with payers and providers

In a marketplace that increasingly demands more comparative evidence of high-cost treatments, health outcomes and economic evaluations of a disease state can help differentiate products and drive market access. Our quality improvement programs range from traditional partnerships — including educational programs and interventions — to outcome performance measurement that provides value to manufacturers, payers, providers, and patients by increasing access to care.

Contact an expert

Written by experts. Valued by decision-makers.

Formulary Dossiers

As the leader in AMCP Format formulary dossiers, we apply a keen understanding of the reimbursement and formulary decision-making process, key influencers, primary drivers, and dossier utilization to clearly convey your most complex data. Our highly experienced medical writers possess advanced clinical backgrounds and strong familiarity with other formulary templates, including the WellPoint Outcomes-Based Formulary guidelines and the Drug Effectiveness Review Project (DERP) evidence submission protocol.

Learn our science of writing

Global Value Dossiers

We possess a deep knowledge of the access and reimbursement decision-making processes across major global markets and understand the critical drivers and influencers that vary from country to country. Build a global value dossier that meets HTA evidentiary requirements across multiple geographies, while being easily adaptable for local submissions. Our two-plus decades of experience translates into a history of creating the industry’s most respected dossiers for key decision makers.

Let us develop yours

Scientific Publications

Communicate your value through credible publications

Benefit from more than 20 years of experience and an unparalleled level of scientific expertise. Our experts have created hundreds of evidence dossiers, economic models, peer-reviewed posters, and publications for hundreds of brands. With well over 350 published manuscripts in peer-reviewed journals and more than 700 poster presentations and symposia at national conferences, turn to the experts in publication planning to enhance your product's value proposition.

Xcenda publications Contact us